Thrivent Financial for Lutherans
RAIN

Thrivent Financial for Lutherans’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Thrivent Financial for Lutherans’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-28,401
Closed -$158K – 2491
2022
Q2 		$158K Buy
28,401
+12,616
+80% +$43.3K ﹤0.01% 2376
2022
Q1 		$80K Buy
+15,785
New +$127K ﹤0.01% 2479

Other funds holding RAIN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Thrivent Financial for Lutherans's RAIN Position: Q3 2022 in Review

Thrivent Financial for Lutherans sold out of Rain Oncology Inc. Common Stock (RAIN) in Q3 2022, closing a stake of 28,401 shares — an estimated $158K sold.

Thrivent Financial for Lutherans first reported a position in RAIN in Q1 2022 and held it in 2 quarters. The position peaked at $158K in Q2 2022. 38 funds tracked by Wall St. Rank hold RAIN as of Q3 2022.

  • Thrivent Financial for Lutherans reported no remaining Rain Oncology Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 28,401 Rain Oncology Inc. Common Stock shares in Q3 2022, an estimated $158K.
  • Thrivent Financial for Lutherans first reported a position in Rain Oncology Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Thrivent Financial for Lutherans's Rain Oncology Inc. Common Stock position peaked at $158K in Q2 2022.
  • 38 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q3 2022.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2022, filed 14 Nov 2022.